Condition: Penicillin Allergy · Hypersensitivity, Immediate · Hypersensitivity, Delayed · Sponsor: Deniz Göcebe
The aim of this clinical trial is to analyze the negative predictive capacity and safety of risk-stratified direct drug provocation tests for patients with self-reported penicillin allergies. Patients reporting immediate or delayed penicillin allergies and defined as low-risk by the PEN-FAST score will receive drug provocation tests without prior skin testing.
This description comes directly from the study's public registry record.
Deniz Göcebe, MD · +4962215639539 · Deniz.Goecebe@med.uni-heidelberg.de
Knut Schäkel, MD · Knut.Schaekel@med.uni-heidelberg.de
Always discuss trial participation with your own doctor first.
| University Hospital Heidelberg, Dermatology | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
| University Hospital Heidelberg, Division of Infectious Diseases and Tropical Medicine | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06755281